London (PA Media/dpa) – A targeted treatment that triggers the death of cancer cells has shown promise for patients with advanced bowel cancer when used alongside chemotherapy, an early trial has
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

